SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Mind Solutions Inc (OTCMKTS:VOIS) has been dealing with the volatile price movements lately. After recording strong gains in the month of February and at the start of the March the share price made a high of $0.0055 mark, but then quickly started its decline. The deep plunge in the share prices surprised many investors as the company is a progressive technology firm. Besides, it is working on the most advanced form of brain-computer-interface solutions.

Reading numbers

The reason behind the VOIS stock price plunge gets obvious after the balance sheet of Mind Solutions is carefully analyzed. As per the last annual financial numbers posted a couple of weeks ago, Mind Solutions recorded cash of $113,000. The liabilities stood massive at $3 million while the annual revenue came at $100,000. The company recorded an annual loss of $1.4 million. It is evident that the financial numbers are lacking strength.

It becomes all more disappointing for the investors especially when they know the company possesses potential to excel in the industry. Recently, it disclosed that the customers can pre-order mobile BCI from April 28, 2015 onwards, which definitely is cheering news. Despite it, VOIS stock price has failed to record strong gains in the week.

The ride

Earlier in the week, Mind Solutions Inc (OTCMKTS:VOIS) plunged more than 20% to trade near $0.0023. It implies that the total decline that VOIS stock price recorded since its peak in March now stands at 60%. Friday’s trading session brought some relief as the stock price jumped 7.14% to close the day at $0.00150 with share volume of 140.85 million against the average volume of 59.11 million.

Mind Solutions stated that the management met with design entity. All the ergonomic related advancements connected to the mobile BCI device have been done. The BCI device is in the development phase and will be soon available for sale.

SHARE
Previous articleWill It Be Another Failed Acquisition For Medican Enterprises Inc (OTCMKTS:MDCN)?
Next articleMedical Marijuana Inc (OTCMKTS:MJNA) Declines Despite Strong Kannaway Sales Growth
Steve Kanaval: Portfolio Manager/Writer/ Market Analyst Steve began his career in the Trading Pits in Chicago making markets at the Chicago Mercantile Exchange (NYSE:CME) the Chicago Board of Trade and the CBOE in the early 80’s. He ran the Morgan Stanley Derivative Prop Trading for the firm specializing in Index Arbitrage. He continued his career as a Trader/Portfolio Manager for multiple Hedge Funds during the Internet Boom of the 90’s managing large portfolios. Steve is known as an expert in MicroCap Technology Stocks and the emerging Digital Currency markets as a Portfolio Manager for his Family Office. Steve has managed portfolio’s in volatile asset classes for 3 decades as a commodity trader, hedge fund manager and digital currency trader and miner. Steve publishes his views on the asset classes in a public forum and has published more than 10,000 articles simplifying these complex and volatile assets for readers. His work is published on multiple sites including Bloomberg, Equities.com, Hacked.com, CryptoCurrencyNews as a paid contributor. His work includes research, journalism and archived video on important market volatility related to stocks, digital currency and other volatile misunderstood asset classes. He offers a humorous, unique insight and the related back stories and drivers for readers interested in volatility and emerging market assets. Full disclosure Steve is long 25 digital currencies and sits on the board of multiple public companies involved in digital currencies, and owns shares in these companies from time to time.